Routt, Ethan. 2019. “Long Term Outcomes for Basal Cell Carcinoma Treated With Vismodegib Extended Alternate Day Dosing”. SKIN The Journal of Cutaneous Medicine 3 (2):150-51. https://doi.org/10.25251/skin.3.2.32.